{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus Palyam : Questions médicales les plus fréquentes",
"headline": "Virus Palyam : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus Palyam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus Palyam"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Orbivirus",
"url": "https://questionsmedicales.fr/mesh/D018163",
"about": {
"@type": "MedicalCondition",
"name": "Orbivirus",
"code": {
"@type": "MedicalCode",
"code": "D018163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.223.719.550"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus Palyam",
"alternateName": "Palyam Virus",
"code": {
"@type": "MedicalCode",
"code": "D030081",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand. duncan_r_smith@hotmail.com."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Nitwara Wikan",
"url": "https://questionsmedicales.fr/author/Nitwara%20Wikan",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Sittiruk Roytrakul",
"url": "https://questionsmedicales.fr/author/Sittiruk%20Roytrakul",
"affiliation": {
"@type": "Organization",
"name": "National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand."
}
},
{
"@type": "Person",
"name": "Ronaldo Mohana-Borges",
"url": "https://questionsmedicales.fr/author/Ronaldo%20Mohana-Borges",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Structural Biotechnology and Bioengineering, Biophysics Institute Carlos Chagas Filho, Lab C0-36ss, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. mohana@biof.ufrj.br."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Orderly specification and precise laminar deployment of cortical glutamatergic projection neuron types through intermediate progenitors.",
"datePublished": "2024-03-02",
"url": "https://questionsmedicales.fr/article/38645016",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1101/2024.03.01.582863"
}
},
{
"@type": "ScholarlyArticle",
"name": "The development of a novel sexual health promotion intervention for young people with mental ill-health: the PROSPEct project.",
"datePublished": "2024-03-01",
"url": "https://questionsmedicales.fr/article/38429748",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-024-10734-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacist Assessments and Care to Improve Adult Vaccination Rates: A Report from Project IMPACT Vaccine Confidence.",
"datePublished": "2024-03-01",
"url": "https://questionsmedicales.fr/article/38432481",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.japh.2024.102061"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early enteral nutrition support for patients with acute pancreatitis in the inpatient setting: a best practice implementation project.",
"datePublished": "2024-02-29",
"url": "https://questionsmedicales.fr/article/38415812",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/XEB.0000000000000410"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human Papillomavirus (HPV) Vaccine Coverage and Confidence in Italy: A Nationwide Cross-Sectional Study, the OBVIOUS Project.",
"datePublished": "2024-02-12",
"url": "https://questionsmedicales.fr/article/38400170",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/vaccines12020187"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN double brin",
"item": "https://questionsmedicales.fr/mesh/D000086122"
},
{
"@type": "ListItem",
"position": 5,
"name": "Reoviridae",
"item": "https://questionsmedicales.fr/mesh/D012087"
},
{
"@type": "ListItem",
"position": 6,
"name": "Orbivirus",
"item": "https://questionsmedicales.fr/mesh/D018163"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus Palyam",
"item": "https://questionsmedicales.fr/mesh/D030081"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus Palyam - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus Palyam",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus Palyam",
"description": "Comment diagnostiquer une infection par le virus Palyam ?\nQuels tests sont utilisés pour le virus Palyam ?\nLes symptômes aident-ils au diagnostic ?\nLe virus Palyam est-il identifiable par culture ?\nY a-t-il des marqueurs spécifiques pour le virus Palyam ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Pilot+Projects&page=999#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus Palyam",
"description": "Quels sont les symptômes courants du virus Palyam ?\nLes symptômes varient selon les individus ?\nLe virus Palyam cause-t-il des complications graves ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques aux enfants ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Pilot+Projects&page=999#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus Palyam",
"description": "Comment prévenir l'infection par le virus Palyam ?\nLes vaccins existent-ils pour le virus Palyam ?\nLes mesures d'hygiène aident-elles à prévenir l'infection ?\nLes moustiquaires sont-elles efficaces contre le virus Palyam ?\nLes voyages dans certaines zones augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Pilot+Projects&page=999#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus Palyam",
"description": "Quel est le traitement principal pour le virus Palyam ?\nLes antibiotiques sont-ils efficaces contre le virus Palyam ?\nDes antiviraux sont-ils disponibles pour ce virus ?\nComment gérer les symptômes du virus Palyam ?\nLe repos est-il recommandé lors d'une infection ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Pilot+Projects&page=999#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus Palyam",
"description": "Quelles sont les complications possibles du virus Palyam ?\nLes complications sont-elles fréquentes ?\nComment les complications sont-elles traitées ?\nLes complications affectent-elles la récupération ?\nY a-t-il des facteurs de risque pour les complications ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Pilot+Projects&page=999#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus Palyam",
"description": "Quels sont les principaux facteurs de risque pour le virus Palyam ?\nLes personnes âgées sont-elles plus à risque ?\nLes voyageurs sont-ils à risque d'infection ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nY a-t-il des occupations à risque pour le virus Palyam ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Pilot+Projects&page=999#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le virus Palyam ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et la détection de l'ARN viral par PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le virus Palyam ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et la PCR sont couramment utilisés pour identifier le virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter le diagnostic, mais ne suffisent pas seuls."
}
},
{
"@type": "Question",
"name": "Le virus Palyam est-il identifiable par culture ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture du virus est difficile et rarement utilisée pour le diagnostic clinique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour le virus Palyam ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticorps spécifiques peuvent être détectés, mais ils ne sont pas exclusifs au virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du virus Palyam ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier d'une personne à l'autre."
}
},
{
"@type": "Question",
"name": "Le virus Palyam cause-t-il des complications graves ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques peuvent survenir, bien que rares."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, généralement dans les 3 à 7 jours après infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes similaires, mais souvent moins sévères."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus Palyam ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'évitement des piqûres d'insectes et l'utilisation de répulsifs."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour le virus Palyam ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin commercialisé contre le virus Palyam."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène aident-elles à prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures d'hygiène appropriées peuvent réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles efficaces contre le virus Palyam ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de moustiquaires peut aider à prévenir les piqûres d'insectes."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines zones augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques augmente le risque d'infection par le virus."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus Palyam ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre le virus Palyam ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales comme le Palyam."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils disponibles pour ce virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antiviraux spécifiques pour traiter le virus Palyam."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes du virus Palyam ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des symptômes inclut des analgésiques et des antipyrétiques pour la fièvre."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé lors d'une infection ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est conseillé pour aider le corps à combattre l'infection."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du virus Palyam ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des troubles neurologiques et des syndromes hémorragiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares, mais peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement des complications est symptomatique et peut nécessiter des soins intensifs."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la récupération ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent prolonger le temps de récupération et affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de risque pour les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou âgées peuvent avoir un risque accru de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le virus Palyam ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des zones endémiques et un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus susceptibles de développer des complications."
}
},
{
"@type": "Question",
"name": "Les voyageurs sont-ils à risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des régions où le virus est endémique courent un risque accru."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ont un risque accru de développer des formes graves de l'infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des occupations à risque pour le virus Palyam ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs en milieu rural ou en contact avec des animaux peuvent être à risque."
}
}
]
}
]
}
The cerebral cortex comprises diverse types of glutamatergic projection neurons (PNs) generated from radial glial progenitors (RGs) through either direct neurogenesis or indirect neurogenesis (iNG) vi...
- Each IP is fate-restricted to generate a pair of near-identical PNs - Corticogenesis involves the orderly generation of fate-restricted IP temporal cohorts - IP temporal cohorts sequentially as well...
Young people with mental ill-health experience higher rates of high-risk sexual behaviour, have poorer sexual health outcomes, and lower satisfaction with their sexual wellbeing compared to their peer...
We followed the 2022 Medical Research Council (MRC) guidelines for developing and evaluating complex interventions. This involved synthesising evidence from the 'top down' (published evidence) and 'bo...
Existing evidence in the field of sexual health in youth mental health was limited but suggested the need to address sexual wellbeing as a concept broader than an absence of negative health outcomes. ...
Using the MRC Framework has guided the co-design of a potentially promising intervention that addresses the sexual health needs of young people with mental ill-health. The next step is to test the int...
Neglect of vaccination needs among adults results in a needless burden of hospitalization, suffering, and death. America's community pharmacists deliver a substantial portion of adult vaccinations, ye...
This study evaluated rates of vaccine contraindications, acceptance, and willingness to be vaccinated among ambulatory adults....
This was a prospective, multisite, multistate, observational study conducted in three waves between October 2021 and August 2023. Pharmacists conducted comprehensive vaccination need assessments. The ...
Pharmacists identified a mean of 1.8 to 2.2 unmet vaccination needs per adult assessed, more than in pilot studies. Participants had already received 61% to 74% of vaccinations recommended for them, h...
This study provides insight into adult vaccine acceptance, willingness, and declination behaviors not described elsewhere. Offering options for future vaccination reduced declination rates....
Pharmacists resolved substantial proportions of adult vaccination needs. The signal that apportioning adult vaccines needed, but not received on day of assessment, across several months could help res...
Acute pancreatitis is a major disease that endangers the health and lives of people. Historically, clinical therapy has recommended that patients with acute pancreatitis remain nil by mouth. As one of...
This evidence implementation project aimed to increase compliance with best practice recommendations for early enteral nutrition support, while standardizing the enteral nutrition support process and ...
The project was guided by the JBI Evidence Implementation Framework, which is grounded in the audit and feedback process, as well as a seven-stage structured approach to identifying and managing barri...
In the baseline audit, compliance rates were low for all evidence-based audit criteria. Four of the eight criteria showed 0% compliance. However, after implementation, all eight criteria achieved a mi...
This project not only significantly improved early enteral nutrition support for acute pancreatitis patients, but also increased nurses' knowledge and practice skills, standardized the process of ente...
Human Papillomavirus (HPV) vaccination rates are still below the target due to vaccine refusal or delay, lack of knowledge, and logistical challenges. Understanding these barriers is crucial for devel...
This cross-sectional study used a questionnaire to investigate social and behavioral factors influencing decision making about the HPV vaccine. The survey was conducted from 11 April to 29 May 2022 an...
3160 participants were surveyed about themselves, while 1266 respondents were surveyed about their children's vaccine uptake. Among females aged ≥ 26 years, the national average HPV vaccine uptake was...
The OBVIOUS study in Italy reveals factors influencing low HPV vaccine uptake, suggesting targeted approaches, tailored information campaigns, heightened awareness of eligibility, promoting early vacc...
Out-of-hospital cardiac arrest is a major health problem, and the overall survival rate is low (4.6%-16.4%). The initiation of the current chain of survival depends on the presence of a witness of the...
Within the 'Beating Cardiac Arrest' project, we aim to develop a demonstrator product that detects out-of-hospital cardiac arrest using photoplethysmography and accelerometer analysis, and autonomousl...
Primary care is integral to the health system and population health. Primary care research is still in development and most academic departments lack effective research investments. High impact primar...
A descriptive qualitative project with key informants from research programs in primary care. Participants included international research leaders in primary care (n = 10), department of family and co...
At the micro level despite barriers with respect to funding, protected time and lack of formal mentorship, personal motivation was a key factor. At the meso level, the organizational structure that pr...
The alignment/complementarity of micro, meso, and macro level factors influenced the creation of a high impact research department in primary care. High impact research in primary care is facilitated ...
Polypharmacy is a growing phenomenon among elderly individuals. However, there is little information about the frequency of polypharmacy among the elderly population treated in emergency departments (...
A retrospective analysis of the Emergency Department Elderly in Needs (EDEN) project's cohort was performed. This registry included all elderly patients who attended 52 Spanish EDs for any condition. ...
A total of 25,557 patients were evaluated [mean age: 78 (IQR: 71-84) years]; 10,534 (41.2%) and 5678 (22.2%) patients presented with mild and severe polypharmacy, respectively. In the adjusted analysi...
Polypharmacy was common among the elderly treated in EDs and associated with increased risks of ED revisits and hospital readmissions ⩽30 days but not with an increased risk of 30-day mortality. Patie...
In European Union countries, any disease affecting less than 5 people in 10,000 is considered rare. As expertise is scarce and rare diseases (RD) are complex, RD patients can remain undiagnosed for ma...
The RD-CODE project aimed at making those patients identifiable in HIS in order to produce crucial epidemiological data. Undiagnosed patients were defined as patients for whom no clinically-known diso...
The recommendations can now be implemented in HIS (electronic health records and/or registries) and could be a game-changer for patients, clinicians and researchers in the field, enabling assessment o...
We previously implemented paper-based screening for health-related social resource needs (HRSN) in our gynecologic oncology clinic and found that 36% of patients who completed the screening reported H...
A multidisciplinary team consisting of physicians, a health outcomes researcher, a computer programmer, project assistants, and the staff of a partner community organization designed and implemented a...
Screening compliance increased from the baseline of 52% (paper-based) to 97% in PDSA 4. Completion via the online patient portal increased from 17% in prelaunch to 49% in PDSA 4. Of patients who repor...
Compared with paper-based screening, an EMR-integrated HRSN screening and referral system significantly improved reach to patients at a gynecologic oncology clinic. Implementation efforts to expand to...
